Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2007
02/21/2007EP1753725A1 Tetrahydroisoquinoline sulfonamide derivatives, the preparation thereof, and the use of the same in therapeutics
02/21/2007EP1753724A1 Heterocyclic derivatives for treatment of hyperlipidemia and related diseases
02/21/2007EP1753721A1 Aroyl-o-piperidine derivatives for the treatment of diabetes-related problems
02/21/2007EP1753719A1 Substituted pyrrolidine-2-ones
02/21/2007EP1753718A1 3-amino-2-phenylpyrrolidine derivatives
02/21/2007EP1753429A1 Modulators of muscarinic receptors
02/21/2007EP1753421A2 Arylsulfonamides and uses as hydroxysteroid dehydrogenase
02/21/2007EP1581517B1 Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
02/21/2007EP1567488B1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
02/21/2007EP1511727B1 Aromatic sulfones and their medical use
02/21/2007EP1501508B1 Inhibitors of histone deacetylase
02/21/2007EP1355905B1 Pyrazole compounds useful as protein kinase inhibitors
02/21/2007EP1311482B1 Non-imidazole aryloxypiperidines as h3 receptor ligands
02/21/2007EP1255749B1 Tyrosine derivatives with anti-leukotriene activity
02/21/2007EP1000025B1 Substituted naphthopyrans
02/21/2007EP0968193B1 Phenylsulphonyl ureas, processes for their preparation and their use as herbicides and plant-growth regulators
02/21/2007CN1918154A Poly-heterocyclic compounds and their use as metabotropic glutamate receptor antagonists
02/21/2007CN1918148A Substituted benzimidazoles and their use for inducing apoptosis
02/21/2007CN1918147A 1,2,3,4-tetrahydroisoquinoline derivatives, preparations thereof and uses thereof
02/21/2007CN1918146A Aminobenzimidazoles and benzimidazoles as inhibitors of respiratory syncytial virus replication
02/21/2007CN1918145A Amino heterocyclic modulators of chemokine receptor activity
02/21/2007CN1918144A Anthranilamide-based compound, method for producing the same, and pest-controlling agent containing the same
02/21/2007CN1918137A Tetrazole compounds and their use as metabotropic glutamate receptor antagonists
02/21/2007CN1918129A Therapeutic agent
02/21/2007CN1918128A Fused ring 4-oxopyrimidine derivative
02/21/2007CN1918118A Thioamide compound or its salt and cytokine production inhibitor containing the same
02/21/2007CN1917921A Calcitonin gene related peptide receptor antagonists
02/21/2007CN1917881A Novel phenylalanine derivatives
02/21/2007CN1917880A Pyrimidines with tie2 (tek) activity
02/21/2007CN1917879A Pyrimidines with tie2 (tek) activity
02/21/2007CN1917873A Diurea derivatives
02/21/2007CN1915989A Resultant Ruisidilabo from generic delavird and resveratrol, and synthetic method
02/21/2007CN1915988A Resultant Ruisidilasu from generic delavird and resveratrol, and synthetic method
02/21/2007CN1301254C Preparation of catifloxacin and purifying method
02/20/2007US7179922 Chemical compounds
02/20/2007US7179921 Indoline and tetrahydro-quinolines as prodrugs for tumour treatment
02/20/2007US7179839 For therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction
02/20/2007US7179835 2-(3-sulfonylamino-2-oxopyrrolidin-1-yl)propanamides as factor xa inhibitors
02/20/2007US7179825 Such as N-(2-benzotriazolyl)-N'-(4-(1-(1H-imidazol-1-yl)-2-ethylbutyl)phenyl) -thiourea; for treatment of cellular proliferation/differentiation disorders; keratinization; oncology; dermatology
02/20/2007US7179824 Arthropodicidal anthranilamides
02/20/2007US7179823 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity
02/20/2007US7179822 Hetero biaryl derivatives as matrix metalloproteinase inhibitors
02/20/2007US7179821 Potassium/sodium channel blockers; for treatment of multiple sclerosis, spinal cord injury, traumatic brain injury, stroke, bladder irritation and dysfunction, neuropathic pain and chemokine-induced pain
02/20/2007US7179819 Benzyl -urea, -thiourea, or -guanidine derivatives that inhibit the binding of ligands to alpha 4 beta 1 integrin (VLA-4); for therapy and prophylaxis of pathologies associated with VLA-4 mediated cell adhesion, such as inflammatory and autoimmune diseases, and tumor metastasis
02/20/2007US7179816 Chemical derivatives and their application as antitelomerase agents
02/20/2007US7179815 For example, 3-[2(R)-{hydroxycarbonylpropyl-amino}-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[2-fluoro-6-(trifluoromethyl)benzyl]-6-methyl-pyrimidine-2,4(1H,3H)-dione; use in treating prostate cancer, benign prostatic hypertrophy, breast cancer and endometriosis
02/20/2007US7179813 Bicyclic indolyl derivatives and methods for their use as serotonergic agents
02/20/2007US7179811 Such as N-[1-(2-amino-3-methylbutyl)-4-piperidinyl]-3-[(2-methoxyethoxy)(6-methyl-2-pyridinyl)methyl]-7-methyl-3H-imidazo[4,5-b]pyridin-2-amine; infant infections
02/20/2007US7179810 Phthalazinone-piperidino-derivatives as PDE4 inhibitors
02/20/2007US7179807 5-substituted-2-arylpyrazines
02/20/2007US7179806 Δ1-pyrrolines used as pesticides
02/20/2007US7179805 Microbiocides; bactericides
02/20/2007US7179804 Tachykinin receptor antagonists
02/20/2007US7179794 Antibiotics; bactericides
02/20/2007US7179307 Oxidative hair dyes containing plant extracts
02/20/2007CA2371174C Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
02/20/2007CA2325776C Novel analogue compounds of camptothecin, process for preparing them and pharmaceutical compositions containing them
02/20/2007CA2186784C The use of carboxylic acid derivatives as drugs
02/20/2007CA2119745C Nonpeptidyl integrin inhibitors having specificity for gpiibiiia receptor
02/20/2007CA2085192C Fungicidal derivatives of 2-imidazoline-5-ones and 2-imidazoline-5-thiones
02/15/2007WO2007019416A1 Benzimidazole derivatives as sirtuin modulators
02/15/2007WO2007018469A1 Oxopyridyl quinoline amides as nk3 receptor modulators
02/15/2007WO2007018466A1 Alkylpyridyl quinolines as nk3 receptor modulators
02/15/2007WO2007018465A1 Amide alkyl pyridiyl quinolines as nk3 receptor modulators
02/15/2007WO2007018325A1 N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
02/15/2007WO2007018319A1 Pyridylphenol compound and use thereof
02/15/2007WO2007018248A1 Pyridone compound
02/15/2007WO2007018175A1 Anthrapyridone compound and salt thereof, magenta ink composition containing such anthrapyridone compound, and colored body
02/15/2007WO2007018168A1 Acylguanidine derivative or salt thereof
02/15/2007WO2007017890A2 Process for preparation of pantoprazole sodium sesquihydrate and product prepared therby
02/15/2007WO2007017828A2 Oxazolidinone-quinolone hybrids as antibacterial compounds
02/15/2007WO2007017752A1 Substituted triazole derivatives as oxytocin antagonists
02/15/2007WO2007017289A2 Acyltryptophanols for fertility control
02/15/2007WO2007017169A1 Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
02/15/2007WO2007017117A1 Process for the synthesis of rosuvastatin calcium
02/15/2007WO2007017114A1 New substituted azathymidine derivatives and their use in the treatment of bacterial infectious diseases
02/15/2007WO2007017096A1 Pyrazine derivatives useful as adenosine receptor antagonists
02/15/2007WO2006136829A3 Pyrazole derivatives and their use as pka and pkb modulators
02/15/2007WO2006135649A3 Aminoquinoline and aminoquinazoline kinase modulators
02/15/2007WO2006125641A3 Pyridine compounds for combating arthropod pests and nematodes
02/15/2007WO2006113606A3 Histone deacetylase inhibitors
02/15/2007WO2006103119A3 Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
02/15/2007WO2006076644A3 Heteroaryl sulfonamides and ccr2
02/15/2007WO2005123703A8 Alkynyl derivatives as modulators of metabotropic glutamate receptors
02/15/2007US20070037984 Biphenyl derivatives
02/15/2007US20070037851 Inhibits binding of CCR3 ligands such as eotaxins to their target cells; inhibits physiological effects of binding; therapeutic and prophylactic agents for asthma, rhinitis, dermatitis, urticaria, conjunctivitis, inflammatory bowel; tissue infiltration of eosinophils, basophils, activated T cells
02/15/2007US20070037850 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
02/15/2007US20070037839 useful in Pharmaceutical medicines or pharmacological tools; cytostatic agents; antiproliferative/antineoplastic agents; 2-Anilino-4-[1-isopropyl-2-(hydroxyiminomethyl)imidazol-5-yl]pyrimidine; rheumatoid arthritis; breast cancer
02/15/2007US20070037837 Quinazoline derivatives
02/15/2007US20070037836 Melanin concentrating hormone; obesity and related disorders, anxiety, or depression; trans-4-Bromo-N-{4-[(4-dimethylamino-quinazolin-2-ylamino)-methyl]-cyclohexylmethyl}-2-trifluoromethoxy-benzenesulfonamide
02/15/2007US20070037826 Indolylmaleimide derivatives
02/15/2007US20070037825 Enhancing the effect of radioimmunotherapy in the treatment of tumors
02/15/2007US20070037823 Substituted piperidine and piperazine derivatives as melanocortin-4 receptor modulators
02/15/2007US20070037819 Treating chronic neuropathic or inflammatory pain; [(1-methyl-1H-pyrrol-2-yl)methyl][[1-[(4-pyrazin-2-ylpiperazin-1-yl)acetyl]-4-[3-trifluoromethyl)phenyl]piperid-4-yl]methyl]amine
02/15/2007US20070037808 Anti-inflammatory medicaments
02/15/2007US20070037807 Pyridine compounds as inhibitors of dipeptidyl peptidase IV
02/15/2007US20070037803 Benzimidazole derivatives
02/15/2007US20070037796 e.g. 7-Phenyl-isoquinoline-5-sulfonic acid {2-[3 -(4-nitrophenyl)-propylamino]-ethyl}-amide, dihydrochloride salt; antiviral, antineoplastic, anticarcinogenic agents; neoplasms
02/15/2007US20070037795 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders
02/15/2007US20070037793 2-methyl-1-[2-(4-nitrophenoxy)-ethyl]-1,2,3,4-tetrahydroisoquinolin-6-yl dimethylcarbamate; Acetylcholinesterase inhibitors; selective serotonin reuptake inhibitory; Alzheimer's disease, depression, Huntington's chorea, Pick's disease, tardive dyskinesia, compulsive disorders or panic disorders